Gene · 5345
Papers4,537
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 4,537
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Innate Immune Response to Viral Vectors in Gene Therapy. | Viruses | 2023 | 37766208 | PubTator, text mining | PubMed |
| Highlighting Fibroblasts Activation in Fibrosis: The State-of-The-Art Fibroblast Activation Protein Inhibitor PET Imaging in Cardiovascular Diseases. | J Clin Med | 2023 | 37762974 | PubTator, text mining | PubMed |
| Nebulized Recombinant Tissue Plasminogen Activator (rt-PA) for Acute COVID-19-Induced Respiratory Failure: An Exploratory Proof-of-Concept Trial. | J Clin Med | 2023 | 37762789 | PubTator, text mining | PubMed |
| A High-Throughput Small-Angle X-ray Scattering Assay to Determine the Conformational Change of Plasminogen. | Int J Mol Sci | 2023 | 37762561 | PubTator, text mining | PubMed |
| The Fibrinolytic System and Its Measurement: History, Current Uses and Future Directions for Diagnosis and Treatment. | Int J Mol Sci | 2023 | 37762481 | PubTator, text mining | PubMed |
The Glycosaminoglycan Side Chains and Modular Core Proteins of Heparan Sulphate Proteoglycans and the Varied Ways They Provide Tissue Protection by Regulating Physiological Processes and Cellular Behaviour. | Int J Mol Sci | 2023 | 37762403 | PubTator, text mining | PubMed |
| The Hemostatic System in Newborns and the Risk of Neonatal Thrombosis. | Int J Mol Sci | 2023 | 37762167 | PubTator, text mining | PubMed |
| Thromboelastometry-Guided Individualized Fibrinolytic Treatment for COVID-19-Associated Severe Coagulopathy Complicated by Portal Vein Thrombosis: A Case Report. | Biomedicines | 2023 | 37760902 | PubTator, text mining | PubMed |
| Endothelial Dysfunction and Pregnant COVID-19 Patients with Thrombophilia: A Narrative Review. | Biomedicines | 2023 | 37760899 | PubTator, text mining | PubMed |
| Viral SERPINS-A Family of Highly Potent Immune-Modulating Therapeutic Proteins. | Biomolecules | 2023 | 37759793 | PubTator, text mining | PubMed |
| Identification of Genes and miRNAs Associated with TAFI-Related Thrombosis: An in Silico Study. | Biomolecules | 2023 | 37759718 | PubTator, text mining | PubMed |
| Impaired fibrinolysis and increased clot strength are potential risk factors for thrombosis in lymphoma. | Blood Adv | 2023 | 37756519 | PubTator, text mining | PubMed |
| Combined FOLFOX4 with all-trans retinoic acid versus FOLFOX4 with placebo in treatment of advanced hepatocellular carcinoma with extrahepatic metastasis: a randomized, double-blind comparative study. | Signal Transduct Target Ther | 2023 | 37752117 | PubTator, text mining | PubMed |
| Fibrinolytic potential as a risk factor for postpartum hemorrhage. | Front Med (Lausanne) | 2023 | 37746089 | PubTator, text mining | PubMed |
| Citrullination of α2-antiplasmin is unlikely to contribute to enhanced plasmin generation in COVID-19 pathophysiology. | Res Pract Thromb Haemost | 2023 | 37736033 | PubTator, text mining | PubMed |
| Diabetes- versus smoking-related thrombo-inflammation in peripheral artery disease. | Cardiovasc Diabetol | 2023 | 37735399 | PubTator, text mining | PubMed |
| COVID-19-associated coagulopathy and acute kidney injury in critically ill patients. | Einstein (Sao Paulo) | 2023 | 37729353 | PubTator, text mining | PubMed |
| A dual role for ERK-1/2 in the regulation of plasmin activity and cell migration in metastatic NSCLC-H1299 cells. | Arch Toxicol | 2023 | 37712947 | PubTator, text mining | PubMed |
| Human plasma kallikrein: roles in coagulation, fibrinolysis, inflammation pathways, and beyond. | Front Physiol | 2023 | 37711466 | PubTator, text mining | PubMed |
| Early identification of lung cancer patients with venous thromboembolism: development and validation of a risk prediction model. | Thromb J | 2023 | 37710256 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5345/papers?page=14